Product
MACI
1 clinical trial
4 indications
Indication
Chondral DefectIndication
Osteochondritis Dissecans (OCD)Indication
Articular Cartilage DefectIndication
Articular Cartilage Disorder of KneeClinical trial
A Prospective, Open-label, Randomized, Concurrent Active-controlled, Longitudinal, Multicenter, Phase 3 Clinical Study of the Safety and Efficacy of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the KneeStatus: Recruiting, Estimated PCD: 2027-06-01